Cormedix (NASDAQ: CRMD) net income
Cormedix reported a net profit of $163.1m for fiscal 2025; in fiscal 2024 it reported a net loss of $17.9m. Its net margin was 52.3%. Earnings per share were $2.25.
Fiscal 2025 is the highest of the 10 fiscal years on record for Cormedix. It reported a loss in 9 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | $163.1m | — | 52.3% | $2.25 |
| 2024 | −$17.9m | — | −41.2% | −$0.30 |
| 2023 | −$46.3m | — | — | −$0.91 |
| 2022 | −$29.7m | — | −45,409.9% | −$0.74 |
| 2021 | −$28.2m | — | −14,774.7% | −$0.75 |
| 2020 | −$22.0m | — | −9,207.7% | — |
| 2019 | −$16.4m | — | −5,801.3% | — |
| 2018 | −$26.8m | — | −6,242.4% | — |
| 2017 | −$33.0m | — | −10,023.4% | — |
| 2016 | −$24.6m | — | −10,996.5% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Cormedix net income compared with its sector
By net income for its latest fiscal year, Cormedix ranks 100th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Cormedix, 52.3%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 98th | Concentra Group Holdings Parent | $166.4m | 7.7% |
| 99th | Pediatrix Medical Group | $165.4m | 8.6% |
| 100th | Cormedix | $163.1m | 52.3% |
| 101st | Harmony Biosciences | $158.7m | 18.3% |
| 102nd | Bausch Health Companies | $157.0m | 1.5% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Cormedix
- How much did Cormedix earn in fiscal 2025?
- Cormedix reported a net profit of $163.1m for fiscal 2025. In fiscal 2024 it reported a net loss of $17.9m.
- What are the earnings per share of Cormedix?
- They were $2.25 in fiscal 2025, compared with −$0.30 in fiscal 2024.
- What is the net margin of Cormedix?
- In fiscal 2025 its net profit was 52.3% of its revenue.
- What was the most profitable year for Cormedix?
- Of its last 10 fiscal years, fiscal 2025, with $163.1m.
- Where does Cormedix rank in its sector by net income?
- It ranks 100th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Cormedix come from?
- From the annual report (Form 10-K) that Cormedix files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Cormedix files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Cormedix: the Cormedix page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.